ChemicalBook > CAS DataBase List > GSK864
GSK864
- Product Name
- GSK864
- CAS No.
- 1816331-66-4
- Chemical Name
- GSK864
- Synonyms
- GSK864;GSK864,GSK-864;GSK864 >=98% (HPLC);(7S)-1-[(4-fluorophenyl)methyl]-N3-(4-methoxy-3,5-dimethylphenyl)-7-methyl-5-(1H-pyrrole-2-carbonyl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-3,7-dicarboxamide;1H-Pyrazolo[4,3-c]pyridine-3,7-dicarboxamide, 1-[(4-fluorophenyl)methyl]-4,5,6,7-tetrahydro-N3-(4-methoxy-3,5-dimethylphenyl)-7-methyl-5-(1H-pyrrol-2-ylcarbonyl)-, (7S)-
- CBNumber
- CB63171695
- Molecular Formula
- C30H31FN6O4
- Formula Weight
- 558.6
- MOL File
- 1816331-66-4.mol
More
Less
GSK864 Property
- Boiling point:
- 782.9±60.0 °C(Predicted)
- Density
- 1.37±0.1 g/cm3(Predicted)
- storage temp.
- 2-8°C
- solubility
- DMF:20.0(Max Conc. mg/mL);35.8(Max Conc. mM)
DMSO:60.0(Max Conc. mg/mL);107.41(Max Conc. mM)
Ethanol:20.0(Max Conc. mg/mL);35.8(Max Conc. mM)
Ethanol:PBS (pH 7.2) (1:1):0.5(Max Conc. mg/mL);0.9(Max Conc. mM) - pka
- 11.73±0.70(Predicted)
- form
- powder
- color
- white to beige
- optical activity
- [α]/D -66 to -76°, c = 0.5 in methanol
More
Less
N-Bromosuccinimide Price
Sigma-Aldrich
- Product number
- SML1757
- Product name
- GSK864
- Purity
- ≥98% (HPLC)
- Packaging
- 5MG
- Price
- $312
- Updated
- 2023/06/20
Sigma-Aldrich
- Product number
- SML1757
- Product name
- GSK864
- Purity
- ≥98% (HPLC)
- Packaging
- 25MG
- Price
- $1210
- Updated
- 2023/06/20
Cayman Chemical
- Product number
- 18762
- Product name
- GSK864
- Purity
- ≥98%
- Packaging
- 500μg
- Price
- $37
- Updated
- 2024/03/01
Cayman Chemical
- Product number
- 18762
- Product name
- GSK864
- Purity
- ≥98%
- Packaging
- 1mg
- Price
- $65
- Updated
- 2024/03/01
Cayman Chemical
- Product number
- 18762
- Product name
- GSK864
- Purity
- ≥98%
- Packaging
- 5mg
- Price
- $266
- Updated
- 2024/03/01
More
Less
GSK864 Chemical Properties,Usage,Production
Biochem/physiol Actions
GSK864 is a cell penetrant, potent and selective allosteric inhibitor of isocitrate dehydrogenase 1 (IDH1) that potently inhibits intracellular 2-hydroxyglutarate (2-HG) production in HT-1080 cells. It appears that GSK864 binds to an allosteric binding site and locks WT and mutant IDH1s in a catalytically inactive conformation. GSK864 is a highly bioavailable analog of GSK321. For full characterization details, please visit the GSK864 probe summary on the Structural Genomics Consortium (SGC) website.To learn about other SGC chemical probes for protein targets, visit sigma.com/sgc
GSK864 Preparation Products And Raw materials
Raw materials
Preparation Products
More
Less
GSK864 Suppliers
1816331-66-4, GSK864Related Search:
GSK2837808A
GSK6853
GSK-A1
S)-1-(sec-butyl)-N-((4,6-diMethyl-2-oxo-1,2-dihydropyridin-3-yl)Methyl)-3-Methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxaMide
GSK484
GSK J4 HCl
GSK 2334470
GSK2982772
GSK2636771
Benzeneacetamide, α-[[6-(4-amino-1-piperidinyl)-3,5-dicyano-4-ethyl-2-pyridinyl]thio]-
GSK778
N-(6-Fluoro-1H-indazol-5-yl)-2-methyl-6-oxo-4-[4-(trifluoromethyl)phenyl]-1,4,5,6-tetrahydro-3-pyridinecarboxamide
GSK 2033
2-((4-(benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl dihydrogen phosphate
N-((S)-1-(4-((S)-2-(2,4-dichlorophenylsulfonaMido)-3-hydroxypropanoyl)piperazin-1-yl)-4-Methyl-1-oxopentan-2-yl)benzo[b]thiophene-2-carboxaMide
GSK-2256098
GSK215